1. Home
  2. AGEN vs SLQT Comparison

AGEN vs SLQT Comparison

Compare AGEN & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.93

Market Cap

178.2M

Sector

Health Care

ML Signal

HOLD

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

HOLD

Current Price

$0.81

Market Cap

151.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
SLQT
Founded
1994
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
178.2M
151.6M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
AGEN
SLQT
Price
$3.93
$0.81
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$14.50
$2.88
AVG Volume (30 Days)
1.0M
840.8K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
105.00
EPS
N/A
0.01
Revenue
$42,877,086.00
$1,526,594,000.00
Revenue This Year
$107.63
$10.97
Revenue Next Year
N/A
$6.14
P/E Ratio
$8.89
$76.61
Revenue Growth
89.95
15.50
52 Week Low
$2.63
$0.56
52 Week High
$7.34
$3.43

Technical Indicators

Market Signals
Indicator
AGEN
SLQT
Relative Strength Index (RSI) 49.56 61.74
Support Level $2.96 $0.56
Resistance Level $4.58 $0.94
Average True Range (ATR) 0.42 0.05
MACD -0.03 0.03
Stochastic Oscillator 37.53 92.22

Price Performance

Historical Comparison
AGEN
SLQT

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Share on Social Networks: